Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment

Clinical trial NCT00447694 · COMPLETED

Trial details

NCT number: NCT00447694
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Beta-thalassemia Iron Overload

Start date: 2006-02-01
Primary completion: 2009-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.